155 related articles for article (PubMed ID: 31826297)
1. A simplified method for therapeutic drug monitoring of mitotane by gas chromatography-electron ionization-mass spectrometry.
Ando M; Hirabatake M; Yasui H; Fukushima S; Sugioka N; Hashida T
Biomed Chromatogr; 2020 Mar; 34(3):e4776. PubMed ID: 31826297
[TBL] [Abstract][Full Text] [Related]
2. [Mitotane in the treatment of adrenal carcinoma].
Sane T
Duodecim; 2010; 126(17):2040-6. PubMed ID: 21053521
[TBL] [Abstract][Full Text] [Related]
3. Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring.
Kerkhofs TM; Derijks LJ; Ettaieb MH; Eekhoff EM; Neef C; Gelderblom H; den Hartigh J; Guchelaar HJ; Haak HR
Eur J Endocrinol; 2014 Dec; 171(6):677-83. PubMed ID: 25201518
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.
Feliu C; Cazaubon Y; Guillemin H; Vautier D; Oget O; Millart H; Gozalo C; Djerada Z
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28432798
[TBL] [Abstract][Full Text] [Related]
5. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
[TBL] [Abstract][Full Text] [Related]
6. High-Dose Mitotane-Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma.
Pape E; Feliu C; Yéléhé-Okouma M; Colling N; Djerada Z; Gambier N; Weryha G; Scala-Bertola J
Oncologist; 2018 Mar; 23(3):389-390. PubMed ID: 29192018
[No Abstract] [Full Text] [Related]
7. Contribution of Therapeutic Monitoring in the Assessment of Toxic Adverse Effects of Mitotane: a Case Report.
Jebabli N; Gaïes E; Eljebari H; Charfi R; Lakhal M; Klouz A; Salouage I; Trabelsi S
Therapie; 2015; 70(6):545-6. PubMed ID: 26242497
[TBL] [Abstract][Full Text] [Related]
8. Mitotane serum level analysis; good agreement between two different assays.
Hermsen IG; den Hartigh J; Haak HR
Clin Endocrinol (Oxf); 2010 Aug; 73(2):271-2. PubMed ID: 20105188
[No Abstract] [Full Text] [Related]
9. Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patients.
Arshad U; Taubert M; Kurlbaum M; Frechen S; Herterich S; Megerle F; Hamacher S; Fassnacht M; Fuhr U; Kroiss M
Eur J Endocrinol; 2018 Oct; 179(5):287-297. PubMed ID: 30087117
[TBL] [Abstract][Full Text] [Related]
10. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma.
Andersen A; Warren DJ; Nome O; Vesterhus L; Slørdal L
Ther Drug Monit; 1995 Oct; 17(5):526-31. PubMed ID: 8585118
[TBL] [Abstract][Full Text] [Related]
11. Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma.
Kerkhofs TM; Derijks LJ; Ettaieb H; den Hartigh J; Neef K; Gelderblom H; Guchelaar HJ; Haak HR
Ther Drug Monit; 2015 Feb; 37(1):58-65. PubMed ID: 24887633
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.
Kerkhofs TM; Baudin E; Terzolo M; Allolio B; Chadarevian R; Mueller HH; Skogseid B; Leboulleux S; Mantero F; Haak HR; Fassnacht M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4759-67. PubMed ID: 24057287
[TBL] [Abstract][Full Text] [Related]
13. A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring.
Friedl B; Kurlbaum M; Kroiss M; Fassnacht M; Scherf-Clavel O
Anal Bioanal Chem; 2019 Jul; 411(17):3951-3962. PubMed ID: 31093700
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous analysis of mitotane and its main metabolites in human blood and urine samples by SPE-HPLC technique.
Mornar A; Sertić M; Turk N; Nigović B; Koršić M
Biomed Chromatogr; 2012 Nov; 26(11):1308-14. PubMed ID: 22259022
[TBL] [Abstract][Full Text] [Related]
15. High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up.
Mauclère-Denost S; Leboulleux S; Borget I; Paci A; Young J; Al Ghuzlan A; Deandreis D; Drouard L; Tabarin A; Chanson P; Schlumberger M; Baudin E
Eur J Endocrinol; 2012 Feb; 166(2):261-8. PubMed ID: 22048971
[TBL] [Abstract][Full Text] [Related]
16. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer.
Terzolo M; Pia A; Berruti A; Osella G; Alì A; Carbone V; Testa E; Dogliotti L; Angeli A
J Clin Endocrinol Metab; 2000 Jun; 85(6):2234-8. PubMed ID: 10852456
[TBL] [Abstract][Full Text] [Related]
17. Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma.
Reimondo G; Puglisi S; Zaggia B; Basile V; Saba L; Perotti P; De Francia S; Volante M; Zatelli MC; Cannavò S; Terzolo M
Eur J Endocrinol; 2017 Oct; 177(4):361-367. PubMed ID: 28780517
[TBL] [Abstract][Full Text] [Related]
18. A case report of neurological adverse events caused by short-term and low-dose treatment of mitotane: The role of therapeutic drug monitoring.
Liu X; Fu Q; Tang Y; Deng JH; Mei D; Zhang B
Medicine (Baltimore); 2020 Oct; 99(40):e22620. PubMed ID: 33019484
[TBL] [Abstract][Full Text] [Related]
19. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
Lecka A; Ginalska-Malinowska M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
[TBL] [Abstract][Full Text] [Related]
20. The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging.
Haider MS; Ahmad T; Groll J; Scherf-Clavel O; Kroiss M; Luxenhofer R
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):575-593. PubMed ID: 34287806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
